Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Intangibles (2023 - 2025)

Historic Change in Intangibles for Adma Biologics (ADMA) over the last 3 years, with Q2 2025 value amounting to $105000.0.

  • Adma Biologics' Change in Intangibles fell 6488.29% to $105000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $117000.0, marking a year-over-year decrease of 7932.86%. This contributed to the annual value of $349000.0 for FY2024, which is 6619.05% up from last year.
  • Latest data reveals that Adma Biologics reported Change in Intangibles of $105000.0 as of Q2 2025, which was down 6488.29% from $19000.0 recorded in Q1 2025.
  • Adma Biologics' Change in Intangibles' 5-year high stood at $299000.0 during Q2 2024, with a 5-year trough of -$7000.0 in Q4 2024.
  • In the last 3 years, Adma Biologics' Change in Intangibles had a median value of $42000.0 in 2024 and averaged $97571.4.
  • As far as peak fluctuations go, Adma Biologics' Change in Intangibles plummeted by 10333.33% in 2024, and later surged by 2666.67% in 2025.
  • Over the past 3 years, Adma Biologics' Change in Intangibles (Quarter) stood at $210000.0 in 2023, then plummeted by 103.33% to -$7000.0 in 2024, then skyrocketed by 1600.0% to $105000.0 in 2025.
  • Its Change in Intangibles stands at $105000.0 for Q2 2025, versus $19000.0 for Q1 2025 and -$7000.0 for Q4 2024.